Oncare Secures $1 Mn In Seed Funding Led By Huddle Ventures

A cancer care startup Oncare raised USD 1 million in a seed funding round led by Huddle Ventures. The round also saw participation from marquee institutional venture capitals such as TRTL Ventures, Cloud Capital, and DeVC.

Founded in 2023 by Deepak Kumar and Amar Sneh, Oncare is partnering with 50-100 bedded hospitals to create dedicated oncology wings. Through these partnerships, Oncare claimed that it is reducing treatment costs by up to 40 per cent. The brand said it aims to offer an affordable yet high-quality alternative to expensive cancer treatment—often exceeding Rs 10 lakh in corporate hospitals.  

Emerging as a silent epidemic, the cancer burden in India is staggering, with annual cases expected to rise from 1.39 million in 2020 to 1.57 million by 2025, according to the annual health of nation report by Apollo Hospitals. However, high treatment costs, limited availability of oncology centres, and a shortage of specialised professionals are making cancer care inaccessible to millions. Recognising these challenges, Oncare said that it is stepping in with an innovative model that aims to bridge this gap by making specialised cancer care both affordable and accessible, as per the press release.

The startup plans to deploy the raised capital to expand its operations to 10 new centres across Delhi NCR, Bangalore, and Jaipur over the next two years. The funds will also be channelled towards team expansion and marketing efforts to raise awareness about the brand’s affordable cancer care solutions.

Speaking on the funding, Oncare Co-founder Deepak Kumar said, “The increasing burden of cancer in India is staggering, and unfortunately, many families are forced to make tough decisions due to the exorbitant costs of treatment. At Oncare, we aim to alleviate this burden by providing affordable, high-quality cancer care. This funding will help us expand our services to more patients, ensuring that every family can access the care their loved ones need without financial ruin.”

Sanil Sachar, Founding Partner, Huddle Ventures, expressed his confidence in Oncare’s potential to reshape the future of cancer care, and said, “Quality healthcare is a fundamental right, yet it remains inaccessible to many across various economic strata. We see a significant gap in the consistency and accessibility of cancer care that every patient deserves. By backing Oncare, our goal is to ensure the delivery of high-quality, affordable oncology treatments across the country. Oncology demands an immense level of trust at every stage of treatment, and Oncare has consistently demonstrated its ability to build this trust through its meticulous execution and adherence to strict protocols.”